Hoodia is a southern African desert plant used in oral supplements for appetite suppression and weight control. Human evidence is low quality, with no high- or medium-level benefits. Low-dose whole-plant preparations modestly reduced short-term hunger, weight, and waist size, whereas purified extract failed to reduce calorie intake or weight and raised blood pressure, heart rate, bile pigments, nausea, vomiting, and abnormal skin sensations. Commercial product contamination is widespread. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Seated Blood Pressure | No established target; change from individual baseline is tracked | Safety check: detects sympathomimetic systolic and diastolic pressor spikes that require stopping use |
| Resting Heart Rate and 12-Lead ECG | Heart rate 60–100 bpm (standard reference range); PR interval 120–200 ms (standard reference range) | Safety check: detects resting tachycardia, PR prolongation, or QT shortening that require stopping use |
| Serum Total Bilirubin and ALP | Total bilirubin 0.2–1.2 mg/dL (standard reference range); ALP 44–147 IU/L (standard reference range) | Safety check: detects reversible cholestatic or biliary stress that requires stopping use |
| Serum ALT and AST | ALT 7–56 IU/L (standard reference range); AST 8–33 IU/L (standard reference range) | Safety check: detects hepatocellular injury from adulterated or multi-ingredient products that requires stopping use |
| Blood Urea Nitrogen (BUN) | 7–20 mg/dL (standard reference range) | Safety check and expected-change marker: tracks nitrogen metabolism shifts reported during extract use |
| Body Weight and Waist Circumference | No established target; change from individual baseline is tracked | Expected-change marker: evaluates whether low-dose H. parviflora reduces adiposity |
Cadence: Baseline prior to initiation; seated blood pressure and resting heart rate every 2–3 days during the first 2 weeks and weekly thereafter; 12-lead ECG at baseline and day 14; fasting hepatobiliary and renal blood panels (bilirubin, ALP, ALT, AST, and BUN) and anthropometric measurements repeated at 2 and 4 weeks.